http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36058361

Outgoing Links

Predicate Object
contentType Journal Article
issn 1471-2407
issueIdentifier 1
pageRange 956-
publicationName BMC Cancer
startingPage 956
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d70b6b4d1a4490851c4f48f77c39c6f4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1c0aa062611518a12552a116a65f748d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0870048dc7dde17e741bdfd98c424b7f
bibliographicCitation Zhenhai Z, Qi C, Shuchao Z, Zhongqi W, Xue S, Zhijun G, Zhijie M, Jianmin L, Beibei L, Yuanyuan G. MiR-205-3p suppresses bladder cancer progression via GLO1 mediated P38/ERK activation. BMC Cancer. 2023 Oct 09;23(1):956. PMID: 37814205; PMCID: PMC10563299.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e523244854ba07bb07fad1ecf2ed70f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e11f4d84d2bb294e9a39e62fef3ee5e8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b897550a5617e0313f7c3e40d8f7ad97
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cdae1928981bf213402c17c78d7c08e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_903dc37348811b00a5458f17658c8d77
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_115d84775b7b4a795fbfeb984171049e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61153f28f08932f73deaff03c6e88c69
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80af23ae67710c9c479af29eca1f26d6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_918b425afb874356bba6adea750805c8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ccf0822582ba9ed3c725c8c567b99258
date 2023-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC10563299
https://doi.org/10.1186/s12885-023-11175-9
https://pubmed.ncbi.nlm.nih.gov/37814205
isPartOf https://portal.issn.org/resource/ISSN/1471-2407
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title MiR-205-3p suppresses bladder cancer progression via GLO1 mediated P38/ERK activation
discusses http://id.nlm.nih.gov/mesh/M000604946
http://id.nlm.nih.gov/mesh/M0012185
http://id.nlm.nih.gov/mesh/M0407989
http://id.nlm.nih.gov/mesh/M0528623

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2739
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID406988

Total number of triples: 37.